Published in Int Urogynecol J Pelvic Floor Dysfunct on February 17, 2007
Affective Temperament Profiles of Overactive Bladder Patients. Noro Psikiyatr Ars (2014) 0.83
Incontinence and mood disorder: is there an association? BMJ Case Rep (2010) 0.77
Positive association of female overactive bladder symptoms and estrogen deprivation: A nationwide population-based cohort study in Taiwan. Medicine (Baltimore) (2016) 0.75
Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res (1994) 6.73
Clinical practice. Postpartum depression. N Engl J Med (2002) 2.75
A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry (1993) 2.38
Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol (2003) 1.89
Incontinence severity and major depression in incontinent women. Obstet Gynecol (2005) 1.70
Parturition and urinary incontinence in primiparas. Obstet Gynecol (2001) 1.64
The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc (2000) 1.54
Urinary incontinence and depression. J Urol (1999) 1.51
Urinary incontinence in the 12-month postpartum period. Obstet Gynecol (2003) 1.50
Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand (2001) 1.45
Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. Obstet Gynecol (2002) 1.45
Risk factors and predictive signs of postpartum depression. J Affect Disord (1998) 1.40
Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry (1998) 1.31
Influence of central serotonergic mechanisms on lower urinary tract function. Urology (2002) 1.28
Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG (2004) 1.24
Urge incontinence: new health-related quality of life measures. J Am Geriatr Soc (1999) 1.23
Psychosocial predictors of depressive symptomatology level in postpartum women. J Affect Disord (1997) 1.21
Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. Am J Obstet Gynecol (2002) 1.18
Prevalence and risk factors of urinary incontinence in young and middle-aged women. BJU Int (2002) 1.18
Postpartum depression: a comparison of screening and routine clinical evaluation. Am J Obstet Gynecol (2000) 1.16
Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol (2004) 1.12
Obstetric risk factors for postnatal depression in urban and rural community samples. Aust N Z J Psychiatry (2001) 1.11
Use of the Edinburgh Postnatal Depression Scale to identify postpartum depression in a clinical setting. J Reprod Med (1994) 1.07
Screening for postpartum depression in an inner-city population. Am J Obstet Gynecol (2003) 1.05
Obstetric risk factors for stress urinary incontinence: a population-based study. Obstet Gynecol (2000) 1.03
Diagnosing postpartum depression: can we do better? Am J Obstet Gynecol (2002) 1.01
Depression and incontinence. World J Urol (2001) 0.97
Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. J Urol (2003) 0.87
Socio-environmental factors and postnatal depressive symptomatology: a longitudinal study. Women Health (1999) 0.86
An unexpected association between urinary incontinence, depression and sexual dysfunction. Drugs Today (Barc) (2002) 0.77
Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapse. Obstet Gynecol (2007) 4.34
Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey. Am J Epidemiol (2008) 3.02
Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol (2008) 2.57
Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol (2008) 2.52
Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol (2007) 2.25
Urologic complications of diabetes. Diabetes Care (2005) 2.03
Current and future need for academic urologists in the United States. J Urol (2011) 1.86
Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol (2008) 1.77
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry (2005) 1.60
Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol (2002) 1.58
Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause (2010) 1.49
Age effects on internal anal sphincter thickness and diameter in nulliparous females. Dis Colon Rectum (2007) 1.46
Erection of the human penis and its morphological and vascular basis by Guiseppe Conti. J Sex Med (2008) 1.45
Increased phosphodiesterase type 5 levels in a mouse model of type 2 diabetes mellitus. J Sex Med (2012) 1.43
Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol (2002) 1.39
Self-report of difficult defecation is associated with overactive bladder symptoms. Neurourol Urodyn (2010) 1.39
Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review. Arch Intern Med (2007) 1.38
The electronic medical record: how not to communicate. J Urol (2013) 1.38
Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. Menopause (2014) 1.37
Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. Am J Obstet Gynecol (2004) 1.37
Does vaginal closure force differ in the supine and standing positions? Am J Obstet Gynecol (2005) 1.35
Surgical versus nonsurgical treatment of women with pelvic floor dysfunction: patient centered goals at 1 year. J Urol (2008) 1.34
Is abuse causally related to urologic symptoms? Results from the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 1.29
RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem (2002) 1.25
Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry. J Urol (2011) 1.25
Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med (2007) 1.22
Summit on medical school education in sexual health: report of an expert consultation. J Sex Med (2013) 1.22
Distribution of pelvic organ support measures in a population-based sample of middle-aged, community-dwelling African American and white women in southeastern Michigan. Am J Obstet Gynecol (2008) 1.18
Effects of aging on lower urinary tract and pelvic floor function in nulliparous women. Obstet Gynecol (2007) 1.18
Magnetic resonance imaging and 3-dimensional analysis of external anal sphincter anatomy. Obstet Gynecol (2005) 1.17
Relationship between patient report and physician assessment of urinary incontinence severity. Am J Obstet Gynecol (2003) 1.17
Perineal body anatomy in living women: 3-dimensional analysis using thin-slice magnetic resonance imaging. Am J Obstet Gynecol (2010) 1.15
Racial differences in self-reported healthcare seeking and treatment for urinary incontinence in community-dwelling women from the EPI Study. Neurourol Urodyn (2011) 1.14
Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol (2004) 1.12
Fiberoptic imaging of cavernous nerves in vivo. J Urol (2007) 1.04
Racial differences in bother for women with urinary incontinence in the Establishing the Prevalence of Incontinence (EPI) study. Am J Obstet Gynecol (2009) 1.04
Economic cost of fecal incontinence. Dis Colon Rectum (2012) 1.03
Diagnosis and management of epididymitis. Urol Clin North Am (2008) 1.02
The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci (2005) 1.02
Three-dimensional reconstruction of magnetic resonance images of the anal sphincter and correlation between sphincter volume and pressure. Am J Obstet Gynecol (2003) 1.00
Comparative analysis of urinary incontinence severity after autologous fascia pubovaginal sling, pubovaginal sling and tension-free vaginal tape. J Urol (2007) 0.99
Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med (2004) 0.99
Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. J Low Genit Tract Dis (2012) 0.99
Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. Urology (2007) 0.99
Differences in continence system between community-dwelling black and white women with and without urinary incontinence in the EPI study. Am J Obstet Gynecol (2010) 0.97
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study. BJU Int (2006) 0.96
The association of depression, anxiety and nocturia: a systematic review. J Urol (2013) 0.95
Sexual function, quality of life, and severity of anal incontinence after anal sphincteroplasty. Am J Obstet Gynecol (2006) 0.94
Posterior vaginal wall defects and their relation to measures of pelvic floor neuromuscular function and posterior compartment symptoms. Am J Obstet Gynecol (2002) 0.93
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol (2004) 0.93
An improved approach to followup care for the urological patient: drop-in group medical appointments. J Urol (2006) 0.93
Anal sphincter structure and function relationships in aging and fecal incontinence. Am J Obstet Gynecol (2009) 0.93
Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol (2007) 0.92
The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am (2011) 0.92
Structural position of the posterior vagina and pelvic floor in women with and without posterior vaginal prolapse. Am J Obstet Gynecol (2010) 0.91
Posterior vaginal prolapse shape and position changes at maximal Valsalva seen in 3-D MRI-based models. Int Urogynecol J (2012) 0.91
The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health survey. J Urol (2011) 0.89
Defining patients' knowledge and perceptions of vaginal mesh surgery. Female Pelvic Med Reconstr Surg (2013) 0.89
Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey. Ann Epidemiol (2011) 0.88
Multiple perineal abscesses and sinus tracts as a complication of vaginal mesh. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.88
The association of Incontinence Symptom Index scores with urethral function and support. Am J Obstet Gynecol (2008) 0.88
Symptoms of anal incontinence and difficult defecation among women with prolapse and a matched control cohort. Am J Obstet Gynecol (2007) 0.88
Patient-centered treatment goals for pelvic floor disorders: association with quality-of-life and patient satisfaction. Am J Obstet Gynecol (2009) 0.88
Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. J Urol (2003) 0.87
Fecal incontinence in older women: are levator ani defects a factor? Am J Obstet Gynecol (2010) 0.87
Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls. Schizophr Res (2008) 0.86
Are commonly used psychoactive medications associated with lower urinary tract symptoms? Eur J Clin Pharmacol (2011) 0.86
COPING with publication ethics. J Urol (2011) 0.86
Vaginal support as determined by levator ani defect status 6 weeks after primary surgery for pelvic organ prolapse. Int J Gynaecol Obstet (2011) 0.85
Pharmacologic treatment of erectile dysfunction. Rev Urol (2002) 0.85
Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: toward rethinking DSM criteria of sexual dysfunctions. Am J Psychiatry (2007) 0.85
The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder. J Sex Med (2005) 0.85
Long-term patient satisfaction with michigan four-wall sacrospinous ligament suspension for prolapse. Obstet Gynecol (2013) 0.85
Symptom resolution after operative management of complications from transvaginal mesh. Obstet Gynecol (2014) 0.85
Anterior vaginal wall prolapse: assessment and treatment. Clin Obstet Gynecol (2010) 0.85
Self-perceived natural history of pelvic organ prolapse described by women presenting for treatment. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.84
Associations of commonly used medications with urinary incontinence in a community based sample. J Urol (2012) 0.84
In vivo detection of apoptotic cells in the testis using fluorescence labeled annexin V in a mouse model of testicular torsion. J Urol (2006) 0.83
Confocal fluorescence microscopy in a murine model of microdissection testicular sperm extraction to improve sperm retrieval. J Urol (2012) 0.83
Bladder and urethral function in a mouse model of cavernous nerve injury. Neurourol Urodyn (2012) 0.83
Comparison of the main body of the external anal sphincter muscle cross-sectional area between women with and without prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.82
Practicalities and pitfalls of pessaries in older women. Clin Obstet Gynecol (2007) 0.82
The obstetrics and gynecology clerkship: building a better model from past experience. Am J Obstet Gynecol (2004) 0.82
Angiogenesis therapy for the treatment of erectile dysfunction. J Sex Med (2010) 0.81
Are persistent or recurrent symptoms of urinary incontinence after surgery associated with adverse effects on sexual activity or function? Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.81
Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects. Curr Urol Rep (2007) 0.81
Is it time to change the training of urology residents in the United States? J Urol (2005) 0.81
Levator ani defect status and lower urinary tract symptoms in women with pelvic organ prolapse. Int Urogynecol J (2009) 0.81
Origin and characterization of retrograde labeled neurons supplying the rat urethra using fiberoptic confocal fluorescent microscopy in vivo and immunohistochemistry. J Urol (2010) 0.80
Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes. Aging Male (2010) 0.80
Increased expression of heat shock protein 20 and decreased contractile stress in obstructed rat bladder. J Urol (2006) 0.79
Conservative management of pelvic organ prolapse. Clin Obstet Gynecol (2005) 0.79
Colon cancer screening in women. Womens Health (Lond Engl) (2007) 0.78
Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol (2003) 0.78
Racial differences in fecal incontinence in community-dwelling women from the EPI study. Female Pelvic Med Reconstr Surg (2013) 0.78
Current diagnosis and treatment algorithms for anal incontinence. BJU Int (2006) 0.78
Post-reduction stress urinary incontinence rates in posterior versus anterior pelvic organ prolapse: a secondary analysis. Int Urogynecol J (2013) 0.78
Self-reported natural history of recurrent prolapse among women presenting to a tertiary care center. Int J Gynaecol Obstet (2012) 0.78
Fecal incontinence in pregnancy and post partum. Int J Gynaecol Obstet (2009) 0.77
Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram. CNS Drugs (2011) 0.77